Latest Insider Transactions at Certara, Inc. (CERT)
This section provides a real-time view of insider transactions for Certara, Inc. (CERT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Certara, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Certara, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2023
|
Cynthia Collins |
BUY
Exercise of conversion of derivative security
|
Direct |
9,067
+36.91%
|
-
|
|
May 17
2023
|
Nancy Killefer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,067
+36.91%
|
-
|
|
May 17
2023
|
James E Cashman Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
9,067
+1.98%
|
-
|
|
May 11
2023
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
5,000
-2.74%
|
$100,000
$20.82 P/Share
|
|
Apr 14
2023
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
5,000
-2.67%
|
$115,000
$23.66 P/Share
|
|
Mar 31
2023
|
Drayton Virkler PRESIDENT, REG & ACCES |
SELL
Payment of exercise price or tax liability
|
Direct |
1,166
-8.59%
|
$26,818
$23.8 P/Share
|
|
Mar 31
2023
|
Drayton Virkler PRESIDENT, REG & ACCES |
BUY
Exercise of conversion of derivative security
|
Direct |
3,990
+22.71%
|
-
|
|
Mar 31
2023
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
4,426
-2.79%
|
$101,798
$23.8 P/Share
|
|
Mar 31
2023
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
BUY
Exercise of conversion of derivative security
|
Direct |
8,646
+9.54%
|
-
|
|
Mar 31
2023
|
Nicolette D Sherman CHIEF HUMAN RESOURCES OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,251
-7.45%
|
$28,773
$23.8 P/Share
|
|
Mar 31
2023
|
Nicolette D Sherman CHIEF HUMAN RESOURCES OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,990
+19.19%
|
-
|
|
Mar 31
2023
|
Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF |
SELL
Payment of exercise price or tax liability
|
Direct |
4,039
-1.13%
|
$92,897
$23.8 P/Share
|
|
Mar 31
2023
|
Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF |
BUY
Exercise of conversion of derivative security
|
Direct |
8,646
+4.53%
|
-
|
|
Mar 31
2023
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
3,847
-1.03%
|
$88,481
$23.8 P/Share
|
|
Mar 31
2023
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,651
+3.39%
|
-
|
|
Mar 31
2023
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,277
-0.79%
|
$190,371
$23.8 P/Share
|
|
Mar 31
2023
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,302
+2.46%
|
-
|
|
Mar 31
2023
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Payment of exercise price or tax liability
|
Direct |
6,934
-1.24%
|
$159,482
$23.8 P/Share
|
|
Mar 31
2023
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
BUY
Exercise of conversion of derivative security
|
Direct |
8,646
+2.99%
|
-
|
|
Mar 31
2023
|
William F Feehery CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
25,634
-0.59%
|
$589,582
$23.8 P/Share
|
|
Mar 31
2023
|
William F Feehery CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
36,580
+1.64%
|
-
|
|
Mar 06
2023
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
10,000
-5.14%
|
$210,000
$21.45 P/Share
|
|
Feb 02
2023
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
15,000
-7.16%
|
$300,000
$20.0 P/Share
|
|
Dec 08
2022
|
Eqt Avatar Parent L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,954,521
-100.0%
|
$449,317,815
$15.0 P/Share
|
|
Nov 22
2022
|
Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF |
SELL
Open market or private sale
|
Direct |
51,223
-22.59%
|
$768,345
$15.55 P/Share
|
|
Nov 15
2022
|
Mason P Slaine |
SELL
Open market or private sale
|
Direct |
245,793
-27.13%
|
$3,686,895
$15.57 P/Share
|
|
Nov 14
2022
|
Mason P Slaine |
SELL
Open market or private sale
|
Direct |
4,207
-0.46%
|
$63,105
$15.27 P/Share
|
|
Nov 14
2022
|
Matthew M Walsh |
SELL
Open market or private sale
|
Direct |
12,059
-6.7%
|
$168,826
$14.74 P/Share
|
|
Nov 09
2022
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Open market or private sale
|
Direct |
2,387
-3.09%
|
$31,031
$13.48 P/Share
|
|
Nov 01
2022
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,244
-1.58%
|
$14,928
$12.23 P/Share
|
|
Sep 30
2022
|
Drayton Virkler PRESIDENT, REG & ACCES |
SELL
Payment of exercise price or tax liability
|
Direct |
4,004
-29.45%
|
$52,052
$13.31 P/Share
|
|
Sep 30
2022
|
Drayton Virkler PRESIDENT, REG & ACCES |
BUY
Exercise of conversion of derivative security
|
Direct |
13,595
+34.09%
|
-
|
|
Aug 19
2022
|
Stephen M. Mc Lean |
BUY
Open market or private purchase
|
Direct |
20,000
+32.26%
|
$320,000
$16.32 P/Share
|
|
Aug 17
2022
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
25,000
+4.61%
|
$400,000
$16.64 P/Share
|
|
Aug 16
2022
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Open market or private sale
|
Direct |
10,000
-11.3%
|
$170,000
$17.71 P/Share
|
|
Aug 16
2022
|
Eqt Avatar Parent L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,004,418
-16.7%
|
$102,075,106
$17.38 P/Share
|
|
Aug 16
2022
|
Mason P Slaine |
SELL
Open market or private sale
|
Direct |
182,475
-16.7%
|
$3,102,075
$17.38 P/Share
|
|
Aug 01
2022
|
Nicolette D Sherman CHIEF HUMAN RESOURCES OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,812
-9.41%
|
$61,864
$22.99 P/Share
|
|
Jul 01
2022
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Payment of exercise price or tax liability
|
Direct |
884
-0.32%
|
$18,564
$21.46 P/Share
|
|
Jun 08
2022
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Open market or private sale
|
Direct |
10,000
-10.15%
|
$190,000
$19.16 P/Share
|
|
Jun 02
2022
|
Mason P Slaine |
SELL
Open market or private sale
|
Direct |
250,000
-6.62%
|
$4,750,000
$19.55 P/Share
|
|
May 31
2022
|
Eqt Avatar Parent L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,500,000
-4.0%
|
$28,500,000
$19.0 P/Share
|
|
Apr 04
2022
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Open market or private sale
|
Direct |
3,352
-3.29%
|
$73,744
$22.29 P/Share
|
|
Apr 01
2022
|
Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,532
-1.48%
|
$32,172
$21.48 P/Share
|
|
Apr 01
2022
|
Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF |
SELL
Payment of exercise price or tax liability
|
Direct |
1,982
-0.87%
|
$41,622
$21.48 P/Share
|
|
Apr 01
2022
|
William F Feehery CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,255
-0.42%
|
$194,355
$21.48 P/Share
|
|
Apr 01
2022
|
Justin Edge PRES., REGULATORY & ACCESS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,326
-0.59%
|
$48,846
$21.48 P/Share
|
|
Apr 01
2022
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Payment of exercise price or tax liability
|
Direct |
2,870
-1.03%
|
$60,270
$21.48 P/Share
|
|
Apr 01
2022
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,973
-0.8%
|
$83,433
$21.48 P/Share
|
|
Apr 01
2022
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
1,723
-0.82%
|
$36,183
$21.48 P/Share
|